Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.

Steele GD, Richie JP, Wang BS, Mannick JA, Wilson RE. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor. Surg Forum. 1979; 30:132-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.